Pharmacie Centrale DES Hopitaux Pharmaceutical Import Profile — Algeria (DGFT 2022–2026)

Name: Pharmacie Centrale DES Hopitaux Pharmaceutical Import Records from India — 6 Products, $5.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharmacie Centrale DES Hopitaux — Pharmaceutical Importer Profile (2026) | 6 Products, $5.8M Trade | TransData Nexus

Pharmacie Centrale DES Hopitaux

Pharmaceutical Importer · Algeria · Oncology Focus · $5.8M Total Trade · DGFT Verified

Pharmacie Centrale DES Hopitaux is a pharmaceutical importer based in Algeria with a total trade value of $5.8M across 6 products in 3 therapeutic categories. Based on 169 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Pharmacie Centrale DES Hopitaux sources from 19 verified Indian suppliers, with Accure Labs Private Limited accounting for 27.8% of imports.

Pharmacie Centrale DES Hopitaux — Import Portfolio & Supplier Network

Pharmacie Centrale DES Hopitaux import network — 6 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Pharmacie Centrale DES Hopitaux?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Accure Labs Private Limited	$3.8M	152	27.8%
Emcure Pharmaceuticals Limited	$2.1M	123	15.6%
Naprod Life Sciences Private Limited

What Formulations Does Pharmacie Centrale DES Hopitaux Import?

Formulation	Value	Ships
Xylatin 100 (oxaliplatin injection 100	$526.5K	24
Xylatin 100(oxaliplatin injection 100 MG	$376.1K	9
Ongecin 1000 (gemcitabine for	$297.0K	14
Iricol 100 (irinotecan hydrochloride INJ	$250.4K	12
Xylatin 50 (oxaliplatin injection 50 MG)	$218.2K	12
Amphonex 50MG (lyop)[liposomal	$200.0K	4
Pharmaceutical article / ods / product / item finished product : foseal 800 MG tablet 18x10 sevelamer hydrochloride tablets 800MG	$200.0K	4
Asthalin respiratory solution 5 MG ML salbutamol	$180.1K	7
Asthalin respiratory solution 5 MG/ML	$166.8K	7
Ongecin 1000 gemcitabine for injection 1000 MG 10 vails free	$165.0K	4
Ongecin 1000 gemcitabine for injection 1000 MG foc 10	$165.0K	4
Ongecin 1000(gemcitabine for injection 1000 MG)	$160.5K	4
Pharma: foseal 800MG tablets	$150.0K	3
Vesimycin 10 (mitomycin for injection	$150.0K	3
Epirubicin hydrochloride for injection 50MG (epirubicin hydrochloride for injection 50MG)(21715 vials	$150.0K	3

Pharmacie Centrale DES Hopitaux imports 356 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 6 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Oxaliplatin	Advanced Oncology	$2.3M	61	5.0%	3
2	Gemcitabine	Oncology	$2.1M	79	4.5%	4
3	Irinotecan	Oncology	$1.0M	20	2.4%	7
4	Rifampicin	Advanced Antibiotics	$200.0K	4	0.0%	11
5	Mitomycin	Advanced Oncology	$148.7K	3	1.8%	11
6	Thalidomide	Advanced Oncology	$37.5K	2	1.9%	10

Pharmacie Centrale DES Hopitaux imports 6 pharmaceutical products across 3 categories into Algeria totaling $5.8M.

Pharmacie Centrale DES Hopitaux — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharmacie Centrale des Hôpitaux (PCH) is an Algerian Public Establishment with Industrial and Commercial Character (EPIC), operating under the Ministry of Health. Established to supply pharmaceutical products to public health institutions across Algeria, PCH plays a pivotal role in the nation's healthcare system. The company manages a diverse portfolio of over 1,000 pharmaceutical product references, ensuring the availability of essential medications in public health facilities. (pch.dz)

Headquartered in Dar el Beida, Algiers, PCH operates a distribution network covering five regions: Algiers, Oran, Annaba, Biskra, and Bechar. This extensive network facilitates efficient delivery and storage of pharmaceutical products, maintaining quality control and product traceability. PCH's clientele includes both public and private entities, reflecting its comprehensive approach to healthcare provisioning. (pch.dz)

2Distribution Network

PCH's distribution network spans five key regions in Algeria: Algiers, Oran, Annaba, Biskra, and Bechar. This strategic geographic coverage ensures proximity to various public health establishments, enhancing the efficiency of pharmaceutical supply and distribution. The company's logistics capabilities are designed to maintain proper storage conditions and ensure timely delivery, adhering to quality control standards and product traceability requirements. (pch.dz)

3Industry Role

In Algeria's pharmaceutical supply chain, PCH serves as a primary wholesaler and distributor, supplying pharmaceutical products to public health institutions nationwide. Its role is critical in ensuring the availability of essential medications in public health facilities, thereby supporting the national healthcare system. PCH's operations encompass the importation, storage, and distribution of pharmaceutical products, reflecting its integral position in the supply chain. (pch.dz)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Pharmacie Centrale DES Hopitaux

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

PCH's sourcing strategy exhibits a high concentration, with the top five products accounting for 99.4% of its total import value from India. This concentration indicates a strategic focus on specific therapeutic areas, particularly oncology and advanced antibiotics. The substantial import values of products like Oxaliplatin ($2.3M) and Gemcitabine ($2.1M) underscore the company's emphasis on these categories. While this focused approach may streamline procurement and logistics, it also presents a risk if supply disruptions occur. The reliance on a limited number of products suggests that PCH's relationship with its suppliers is stable and well-established, as evidenced by the consistent import volumes over the years.

2Supply Chain Resilience

PCH's supply chain resilience is bolstered by its diversified supplier base, comprising 19 unique Indian pharmaceutical companies. This diversity mitigates the risks associated with dependency on a single supplier. The company's importation of 356 unique formulations further indicates a broad sourcing strategy, reducing vulnerability to supply chain disruptions. However, the concentration in specific therapeutic areas, such as oncology and advanced antibiotics, may expose PCH to risks if there are global shortages or regulatory changes affecting these products. Ensuring compliance with international quality standards and maintaining robust relationships with suppliers are essential for sustaining supply chain resilience.

Importing Pharmaceuticals into Algeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Algeria

1Regulatory Authority & Framework

In Algeria, the Ministry of Pharmaceutical Industry oversees the regulation of pharmaceutical imports. The regulatory framework governing these imports includes Decree No. 24, issued on October 1, 2025, which outlines the requirements, procedures, and compliance obligations for licensing pharmaceutical import establishments. This decree modernizes the application process and strengthens oversight of pharmaceutical import activities. Authorized import establishments are required to align with the new requirements within 12 months of the decree's publication in the Official Journal.

2Import Licensing & GMP

Import licensing requirements in Algeria are governed by Decree No. 24, which sets out the procedures for obtaining authorization to import pharmaceutical products. This includes the submission of an application file, processing and inspection procedures, and rules governing substantial modifications, renewal, and withdrawal of authorizations. Regarding Good Manufacturing Practice (GMP), Algeria recognizes certifications from reputable international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certificates from these recognized organizations to comply with Algerian regulations.

Pharmacie Centrale DES Hopitaux — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

PCH's product strategy focuses on oncology and advanced antibiotics, with the top three categories being Oncology (53.2%), Advanced Oncology (43.4%), and Advanced Antibiotics (3.4%). This focus aligns with the high demand for cancer treatments and advanced antibiotic therapies in Algeria. The substantial import values of products like Oxaliplatin ($2.3M) and Gemcitabine ($2.1M) reflect PCH's commitment to providing essential medications in these therapeutic areas. Market demand, driven by the prevalence of cancer and infectious diseases, influences this strategic focus.

2Sourcing Profile

PCH's sourcing strategy emphasizes generic drug procurement, with a preference for formulations that meet international quality standards. India plays a significant role in PCH's overall procurement, supplying a diverse range of pharmaceutical products. The company's importation of 356 unique formulations from 19 Indian suppliers indicates a broad and diversified sourcing approach, reducing dependency on a single supplier and enhancing supply chain resilience.

3Market Positioning

Based on its product mix, PCH serves the hospital and government tender segments of the Algerian market. By supplying essential medications to public health institutions, PCH ensures the availability of critical treatments in hospitals and clinics across the country. Its focus on oncology and advanced antibiotics positions the company as a key supplier in these high-demand therapeutic areas.

Seller's Guide — How to Become a Supplier to Pharmacie Centrale DES Hopitaux

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with PCH, given the company's substantial import volumes and reliance on Indian pharmaceutical products. Potential suppliers should focus on oncology and advanced antibiotic formulations to align with PCH's strategic focus. Ensuring compliance with Algerian regulatory requirements, including GMP certifications and quality standards, is essential for establishing successful partnerships.

2Requirements & Qualifications

Indian exporters seeking to supply PCH must obtain GMP certifications from recognized international bodies such as EU GMP, WHO GMP, or PIC/S. Additionally, compliance with Algerian import licensing requirements, including the submission of an application file and adherence to inspection procedures, is mandatory. Products must meet quality standards, undergo batch testing, and adhere to labeling requirements in Arabic and French. Serialization mandates must also be fulfilled to ensure product traceability.

3How to Approach

Frequently Asked Questions — Pharmacie Centrale DES Hopitaux

What products does Pharmacie Centrale DES Hopitaux import from India?

Pharmacie Centrale DES Hopitaux imports 6 pharmaceutical products across 3 categories. Top imports: Oxaliplatin ($2.3M), Gemcitabine ($2.1M), Irinotecan ($1.0M), Rifampicin ($200.0K), Mitomycin ($148.7K).

Who supplies pharmaceuticals to Pharmacie Centrale DES Hopitaux from India?

Pharmacie Centrale DES Hopitaux sources from 19 verified Indian suppliers. The primary supplier is Accure Labs Private Limited (27.8% of imports, $3.8M).

What is Pharmacie Centrale DES Hopitaux's total pharmaceutical import value?

Pharmacie Centrale DES Hopitaux's total pharmaceutical import value from India is $5.8M, based on 169 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Pharmacie Centrale DES Hopitaux focus on?

Pharmacie Centrale DES Hopitaux imports across 3 categories. The largest: Oncology (53.2%), Advanced Oncology (43.4%), Advanced Antibiotics (3.4%).

Get Full Pharmacie Centrale DES Hopitaux Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.